Assessing the Value of New Antimicrobials:Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England

Woods, Beth orcid.org/0000-0002-7669-9415, Kearns, Ben, Schmitt, Laetitia Helene Marie orcid.org/0000-0003-1052-488X et al. (15 more authors) (2024) Assessing the Value of New Antimicrobials:Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England. Applied Health Economics and Health Policy. ISSN 1175-5652

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2024. This is an author-produced version of the published paper. Uploaded in accordance with the University’s Research Publications and Open Access policy.

Dates:
  • Accepted: 30 September 2024
  • Published (online): 30 November 2024
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York)
Depositing User: Pure (York)
Date Deposited: 01 Nov 2024 09:40
Last Modified: 03 Apr 2025 23:14
Published Version: https://doi.org/10.1007/s40258-024-00924-x
Status: Published online
Refereed: Yes
Identification Number: 10.1007/s40258-024-00924-x
Open Archives Initiative ID (OAI ID):

Download

Filename: NICE_AMR_Economics_article_12092024_CLEAN.docx

Description: NICE AMR Economics article 12092024 CLEAN

Licence: CC-BY 2.5

Export

Statistics